0.98
price down icon1.85%   -0.0185
after-market アフターアワーズ: .98
loading
前日終値:
$0.9985
開ける:
$0.9985
24時間の取引高:
289.61K
Relative Volume:
0.66
時価総額:
$76.53M
収益:
-
当期純損益:
$-20.59M
株価収益率:
-2.9271
EPS:
-0.3348
ネットキャッシュフロー:
$-17.99M
1週間 パフォーマンス:
-2.97%
1か月 パフォーマンス:
-22.22%
6か月 パフォーマンス:
-11.71%
1年 パフォーマンス:
-36.77%
1日の値動き範囲:
Value
$0.98
$0.9985
1週間の範囲:
Value
$0.9701
$1.09
52週間の値動き範囲:
Value
$0.8401
$1.75

Oncolytics Biotech Inc Stock (ONCY) Company Profile

Name
名前
Oncolytics Biotech Inc
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
27
Name
Twitter
@oncolytics
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
ONCY's Discussions on Twitter

ONCY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ONCY 0.98 76.53M 0 -20.59M -17.99M -0.3348
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-10-06 開始されました Maxim Group Buy
2021-02-17 開始されました H.C. Wainwright Buy

Oncolytics Biotech Inc (ONCY) 最新ニュース

pulisher
Nov 18, 2024

HC Wainwright Has Negative Estimate for ONCY FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Issues Negative Forecast for TSE:ONC Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Leede Financial Weighs in on TSE:ONC FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Oncolytics Biotech (NASDAQ:ONCY) Downgraded to Moderate Buy Rating by Leede Financial - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Oncolytics Biotech (TSE:ONC) Upgraded at Raymond James - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Oncolytics Biotech (NASDAQ:ONCY) Upgraded at Raymond James - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

Oncolytics Biotech (TSE:ONC) Upgraded by Raymond James to Moderate Buy Rating - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Oncolytics Biotech (NASDAQ:ONCY) Downgraded to "Moderate Buy" Rating by Leede Financial - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Oncolytics Biotech (NASDAQ:ONCY) Stock Rating Upgraded by Raymond James - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Research Analysts Issue Forecasts for ONCY FY2024 Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

FY2028 EPS Estimates for TSE:ONC Boosted by HC Wainwright - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Raymond James Has Bearish Forecast for ONCY FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon - Baystreet.ca

Nov 14, 2024
pulisher
Nov 14, 2024

Oncolytics Biotech (NASDAQ:ONCY) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Biotech Companies' Q3 Updates: Promising Cancer Treatments On The Horizon - Barchart

Nov 14, 2024
pulisher
Nov 13, 2024

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail

Nov 13, 2024
pulisher
Nov 13, 2024

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Management - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Oncolytics Biotech Inc - Baystreet.ca

Nov 12, 2024
pulisher
Nov 12, 2024

Oncolytics Biotech® Inc. - Baystreet.ca

Nov 12, 2024
pulisher
Nov 12, 2024

Oncolytics Biotech Inc reports results for the quarter ended September 30Earnings Summary - XM

Nov 12, 2024
pulisher
Nov 12, 2024

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights - PR Newswire

Nov 12, 2024
pulisher
Nov 12, 2024

Oncolytics Bio (ONC-T) QuotePress Release - The Globe and Mail

Nov 12, 2024
pulisher
Nov 11, 2024

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights – Company AnnouncementFT.com - Financial Times

Nov 11, 2024
pulisher
Nov 09, 2024

Oncolytics Biotech (TSE:ONC) Shares Cross Above 200-Day Moving AverageHere's Why - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

International Assets Investment Management LLC Sells 24,069 Shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) - Defense World

Nov 08, 2024
pulisher
Nov 01, 2024

Oncolytics Biotech (TSE:ONC) Stock Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat

Nov 01, 2024
pulisher
Oct 28, 2024

Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference - GuruFocus.com

Oct 28, 2024
pulisher
Oct 26, 2024

Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short Interest - MarketBeat

Oct 26, 2024
pulisher
Oct 16, 2024

What is Oncolytics Biotech, Inc. (ONCY) Stock Return on Shareholders’ Capital? - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Oncolytics Biotech (TSE:ONC) Stock Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Biotech Advances Gain Momentum Amid October’s Rising Breast Cancer Rates and Awareness Efforts - Baystreet.ca

Oct 15, 2024
pulisher
Oct 15, 2024

Ratio Analysis: Unpacking Oncolytics Biotech, Inc. (ONCY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

What was Oncolytics Biotech, Inc. (ONCY)’s performance in the last session? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Oncolytic Virus Therapy Market Set to Witness Significant Growth by 2024-2031:Oncolytics Biotech Inc, Circio - EIN News

Oct 14, 2024
pulisher
Oct 12, 2024

Stocks In Play: Oncolytics Biotech® Inc. - Barchart

Oct 12, 2024
pulisher
Oct 11, 2024

Oncolytics Biotech (NASDAQ:ONCY) Stock Price Down 5.3%Here's Why - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

ONCY Stock Up on Regulatory Update From Breast Cancer Program - MSN

Oct 10, 2024
pulisher
Oct 09, 2024

A new trading data show Oncolytics Biotech, Inc. (ONCY) is showing positive returns. - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Quarterly Snapshot: Quick and Current Ratios for Oncolytics Biotech, Inc. (ONCY) - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

Oncolytics Biotech (TSE:ONC) Shares Down 7.9%Here's Why - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Examining Oncolytics Biotech, Inc. (ONCY) more closely is necessary - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Oncolytics seeking FDA meeting to discuss registration-enabling study - MSN

Oct 08, 2024
pulisher
Oct 07, 2024

ONCY’s 52-Week Rollercoaster: From $0.84 to $2.10 – What’s Next for Investors? - The InvestChronicle

Oct 07, 2024
pulisher
Oct 07, 2024

Global cancer cases surge while biotech firms accelerate treatment innovations - Benefits and Pensions Monitor

Oct 07, 2024
pulisher
Oct 07, 2024

Oncolytics targets accelerated approval for oncolytic virus therapy - Yahoo Finance

Oct 07, 2024
pulisher
Oct 05, 2024

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path - The Malaysian Reserve

Oct 05, 2024
pulisher
Oct 04, 2024

Oncolytics Biotech (TSE:ONC) Stock Price Up 11.8%Should You Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Stocks In Play: Oncolytics Biotech® Inc. By Baystreet.ca - Investing.com Canada

Oct 04, 2024

Oncolytics Biotech Inc (ONCY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):